Stay updated with breaking news from Olpruva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zevra Therapeutics Inc. will acquire Acer Therapeutics Inc. in a $91 million deal that combines two companies with expertise in rare diseases. Acer has struggled since its hot flash drug, ACER-801 (osanetant), failed to hit statistical significance in a phase IIa proof-of-concept study in March 2023. The stumble came amidst the launch of Acer’s Olpruva, a sodium phenylbutyrate for oral suspension therapy approved by the U.S. FDA in late December 2022 for treating urea cycle disorders. The day before the Zevra merger was announced, Acer reacquired the worldwide development, commercialization and economic rights to Olpruva from its development partner, Relief Therapeutics Inc. ....
Relief Therapeutics Holding SA / Key word(s): Agreement/Product Launch Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA™ (ACER-001) with Acer Therapeutics 30-Aug-2023 / 22:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solel. ....
Actor-casting director Abhishek Banerjee, who received a lot of positive response for his role of Hathoda Tyagi in the hit streaming series 'Paatal Lok', has shared that his mother didnt like him in the role and he considers it as an appreciation for playing the role convincingly. | Tellychakkar.com ....